ADRB3 and necrotizing enterocolitis: Additionally, given the known connection between hyperoxia and intestinal damage [79,80], which increases the risk of NEC [41], our data suggest that pharmacological targeting of β3-AR could also be a promising approach for the prevention and treatment of this disease.